The value of the third-party commercial platform is prominent!

Analyzing the current domestic market, basic R&D and clinical research of innovative drugs, many companies use WuXi AppTec, Tigermed and other CXO companies to promote; and commercial promotion and marketing, more and more outstanding pharmaceutical companies choose to cooperate with third-party business Chemical platforms such as Baiyang Pharmaceutical, etc.
to cooperate
.

Through keen insights into the industry, Baiyang Pharmaceutical’s third-party commercialization platform is different from traditional commercial distribution and promotion platforms.
It is mainly manifested in the realization of the quality and efficiency of the industrial chain through full-brand operation, digital marketing and multi-category synergy.
High-quality products are quickly deployed to the national terminal market, which improves the effect of brand publicity and education and precision promotion while addressing the availability of drugs
.

Thanks to the trend of industry segmentation and specialization, the market value of CXO companies in the A-share pharmaceutical sector, mainly WuXi AppTec, Tigermed, Kanglong Chemical, etc.
, has been rising
.
At the same time, an innovative third-party commercialization platform based on Baiyang Pharmaceutical has emerged in the pharmaceutical industry, and its development potential in China is becoming increasingly apparent
.